OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study
Sun‐Young Jung, Myo-Song Kim, Min‐Chul Kim, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 4, pp. 611-617
Open Access | Times Cited: 26
Sun‐Young Jung, Myo-Song Kim, Min‐Chul Kim, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 4, pp. 611-617
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 161
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 161
Richard Conway, Alyssa Grimshaw, Maximilian F. Konig, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 5, pp. 766-775
Open Access | Times Cited: 158
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
Féline P B Kroon, Aurélie Najm, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 422-432
Open Access | Times Cited: 93
Féline P B Kroon, Aurélie Najm, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 422-432
Open Access | Times Cited: 93
COVID-19 in patients with systemic lupus erythematosus: A systematic review
Xue‐Lei Fu, Yan Qian, Xiaohong Jin, et al.
Lupus (2022) Vol. 31, Iss. 6, pp. 684-696
Open Access | Times Cited: 22
Xue‐Lei Fu, Yan Qian, Xiaohong Jin, et al.
Lupus (2022) Vol. 31, Iss. 6, pp. 684-696
Open Access | Times Cited: 22
TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area
Dong Won Park, Yun Jin Kim, Yoon‐Kyoung Sung, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Dong Won Park, Yun Jin Kim, Yoon‐Kyoung Sung, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Systemic Lupus Erythematosus and COVID-19
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 12
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 12
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study
Ying Li, Xiaolan Tian, Chao Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317319-e0317319
Open Access
Ying Li, Xiaolan Tian, Chao Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317319-e0317319
Open Access
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy
Stefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, et al.
Lara D. Veeken (2021) Vol. 60, Iss. SI, pp. SI25-SI36
Open Access | Times Cited: 16
Stefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, et al.
Lara D. Veeken (2021) Vol. 60, Iss. SI, pp. SI25-SI36
Open Access | Times Cited: 16
Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
Е. Л. Насонов, Б. С. Белов, А. М. Лила, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 6, pp. 666-675
Open Access | Times Cited: 13
Е. Л. Насонов, Б. С. Белов, А. М. Лила, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 6, pp. 666-675
Open Access | Times Cited: 13
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273526-e0273526
Open Access | Times Cited: 9
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273526-e0273526
Open Access | Times Cited: 9
Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort
Ismail A. Walbi, Hassan A. Albarqi, Nayef Saleh Alghanim, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 4
Open Access | Times Cited: 8
Ismail A. Walbi, Hassan A. Albarqi, Nayef Saleh Alghanim, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 4
Open Access | Times Cited: 8
The Impact of The COVID-19 Pandemic On SLE
Xingwang Zhao, Haohao Wu, Shifei Li, et al.
Modern Rheumatology (2023)
Open Access | Times Cited: 4
Xingwang Zhao, Haohao Wu, Shifei Li, et al.
Modern Rheumatology (2023)
Open Access | Times Cited: 4
Look after the COVID ‐19 pandemic: Mortality rates among patients with rheumatic diseases
Ezgi Çimen Güneş, Seda Çolak, Zeynep Belma ŞENLİK, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 3
Closed Access | Times Cited: 1
Ezgi Çimen Güneş, Seda Çolak, Zeynep Belma ŞENLİK, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 3
Closed Access | Times Cited: 1
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review
Yingzi Zhu, Jixin Zhong, Lingli Dong
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 9
Yingzi Zhu, Jixin Zhong, Lingli Dong
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 9
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
Peter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 370-376
Open Access | Times Cited: 5
Peter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 370-376
Open Access | Times Cited: 5
The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia
Ismail A. Walbi, Hussain Alqhtani, Faleh Alqahtani, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 7, pp. 964-970
Open Access | Times Cited: 3
Ismail A. Walbi, Hussain Alqhtani, Faleh Alqahtani, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 7, pp. 964-970
Open Access | Times Cited: 3
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic Review
Daniel Freilich, Jennifer Victory, Anne Gadomski
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Daniel Freilich, Jennifer Victory, Anne Gadomski
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, et al.
Archives of Rheumatology (2022) Vol. 38, Iss. 1, pp. 44-55
Open Access | Times Cited: 2
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, et al.
Archives of Rheumatology (2022) Vol. 38, Iss. 1, pp. 44-55
Open Access | Times Cited: 2
Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study
Jithin Mathew, Siddharth Jain, Terence Susngi, et al.
Rheumatology Advances in Practice (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Jithin Mathew, Siddharth Jain, Terence Susngi, et al.
Rheumatology Advances in Practice (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Efek Obat Imunosupresan Pada Pasien Autoimun dengan COVID-19 (A Scoping Review of The Clinical Evidence)
Oki Nugraha Putra, Mia Arum Anggraini, Hardiyono Hardiyono
Journal of Islamic Pharmacy (2022) Vol. 6, Iss. 2, pp. 88-94
Open Access
Oki Nugraha Putra, Mia Arum Anggraini, Hardiyono Hardiyono
Journal of Islamic Pharmacy (2022) Vol. 6, Iss. 2, pp. 88-94
Open Access
Are immunosuppressant related to unfavorable outcomes in patients COVID-19 with autoimmune rheumatic disease?: A review of clinical evidence
Oki Nugraha Putra, Hardiyono Hardiyono, Mia Arum Anggraini
Deleted Journal (2022) Vol. 49, Iss. 1, pp. 5-14
Open Access
Oki Nugraha Putra, Hardiyono Hardiyono, Mia Arum Anggraini
Deleted Journal (2022) Vol. 49, Iss. 1, pp. 5-14
Open Access
Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial
Vanessa Raabe, Andrew Fleming, Marie I. Samanovic, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Vanessa Raabe, Andrew Fleming, Marie I. Samanovic, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
The Chloroquine Story in the First Year of the COVID-19 Pandemic
Matea Hunić, Renata Teparić, Monika Kovačević, et al.
Kemija u industriji (2022), Iss. 7-8
Open Access
Matea Hunić, Renata Teparić, Monika Kovačević, et al.
Kemija u industriji (2022), Iss. 7-8
Open Access
COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis
Isabela Landsteiner de Sampaio Amêndola, Jonathan Aires Pinheiro, Pedro Póvoa, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6865-6865
Open Access
Isabela Landsteiner de Sampaio Amêndola, Jonathan Aires Pinheiro, Pedro Póvoa, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6865-6865
Open Access
